StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alnylam Pharmaceuticals (ALNY) PT Lowered to $116 at Evercore ISI
May 4, 2018 7:51 AM
Evercore ISI lowered its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Alnylam Pharmaceuticals (ALNY) PT Lowered to $95 at Stifel
May 4, 2018 7:48 AM
Form 8-K ALNYLAM PHARMACEUTICALS, For: May 03
May 3, 2018 4:21 PM
Alnylam Pharma (ALNY) Posts Smaller-than-Expected Q1 Loss
May 3, 2018 4:01 PM
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
May 3, 2018 4:00 PM
Alnylam Pharma (ALNY) Announces Alignment with FDA on Accelerated Development Path for Lumasiran for Primary Hyperoxaluria Type 1
May 3, 2018 7:41 AM
Alnylam Achieves Alignment with FDA on Accelerated Development Path for Lumasiran, an Investigational RNAi Therapeutic for the Treatment of Primary Hyperoxaluria Type 1 (PH1)
May 3, 2018 7:00 AM
